Pancreatic stellate cells (PSCs) occupy the vast majority of the pancreatic most cancers microenvironment, contributing to aggressive conduct of pancreatic most cancers cells (PCCs). Not too long ago, anti-fibrotic brokers have confirmed to be an efficient technique in opposition to most cancers, however medical trials have proven little efficacy, and the driving mechanism stays unknown. N-acetyl-cysteine (NAC) is usually used for pulmonary cystic fibrosis. Pioglitazone, an agonist of peroxisome proliferator-activated receptor gamma, was habitually used for kind II diabetes, however lately reported to inhibit metastasis of PCCs. Nonetheless, few research have centered on the results of those two brokers on most cancers-stromal interactions.
We evaluated the expression of α-smooth muscle actin (α-SMA) and the variety of lipid droplets in PSCs cultured with or with out NAC. We additionally evaluated modifications in invasiveness, viability, and oxidative degree in PSCs and PCCs after NAC remedy. Utilizing an oblique co-culture system, we investigated modifications in viability, invasiveness, and migration of PSCs and PCCs. Mixed remedy results of NAC and Pioglitazone have been evaluated in PSCs and PCCs. In vivo, we co-transplanted KPC-derived organoids and PSCs to guage the results of NAC and Pioglitazone’s mixture remedy on subcutaneous tumor formation and splenic xenografted mouse fashions.
In vitro, NAC inhibited the viability, invasiveness, and migration of PSCs at a low focus, however not these of PCCs. NAC remedy considerably lowered oxidative stress degree and expression of α-SMA, collagen kind I in PSCs, which apparently current a quiescent-like state with a excessive variety of lipid droplets. Co-cultured PSCs and PCCs mutually promoted the viability, invasiveness, and migration of one another. Nonetheless, these promotion results have been attenuated by NAC remedy. Pioglitazone maintained the NAC-induced quiescent-like state of PSCs, which have been reactivated by PCC-supernatant, and enhanced chemosensitivity of PCCs. In vivo, NAC and Pioglitazone’s mixture suppressed tumor development and liver metastasis with fewer stromal elements and oxidative stress degree.
CSE1L, as a novel prognostic marker, promotes pancreatic most cancers proliferation by regulating the AKT/mTOR signaling pathway
Pancreatic most cancers is among the most aggressive tumors with poor prognosis and new targetable therapies are urgently required. CSE1L (chromosome segregation 1 like) is assumed to play an necessary function in tumorigenesis and acts as a most cancers therapeutic goal. Nonetheless, the organic operate and the underlying mechanism of CSE1L in pancreatic most cancers are nonetheless not totally specific. Within the current examine, we discovered that prime CSE1L expression was associated to a worse prognosis in sufferers with pancreatic most cancers in line with information from the Most cancers Genome Atlas (TCGA) database.
Moreover, we discovered that CSE1L knockdown inhibited the proliferation of pancreatic most cancers cells and promoted apoptosis, whereas CSE1L overexpression demonstrated the other phenomenon. Moreover, we found that CSE1L may regulate pancreatic most cancers proliferation by AKT signaling pathway. In abstract, we reveal that CSE1L performs a vital function in tumor development and should function a possible prognostic and therapeutic goal for pancreatic most cancers. PubMed and the Cochrane Library database have been looked for VOC evaluation research
wherein exhaled air was used to detect gastro-oesophageal, liver, pancreatic, and intestinal most cancers in people, High quality evaluation was carried out utilizing the QUADAS-2 standards. Information on diagnostic efficiency, VOCs with discriminative energy, and methodological data have been extracted from the included articles. The literature on VOC evaluation has documented a scarcity of standardization in examine designs. Heterogeneity between the research and inadequate validation of the outcomes make interpretation of the outcomes difficult. To achieve medical applicability, future research on breath evaluation ought to present an correct description of the methodology and validate their findings.
Girdin Knockdown Will increase Gemcitabine Chemosensitivity to Pancreatic Most cancers by Modulating Autophagy
Chemotherapy is essential for the remedy of pancreatic most cancers (PC). Gemcitabine (GEM) because the first-line chemotherapy drug has a excessive resistance charge. Rising the sensitivity of gemcitabine is at present the goals and challenges of this examine. Our earlier examine confirmed Girdin was intently associated to the development and prognosis of PC, indicating that Girdin could also be related to chemosensitivity. Within the present examine, we use recombinant adenovirus to particularly knockdown Girdin in PC cell traces to find out the impact of Girdin within the technique of gemcitabine chemosensitivity.
Autophagy is among the pathways affecting the gemcitabine chemosensitivity in PC. Additional analysis validated that Girdin might activate autophagy by interacting with autophagy protein p62/SQSTM1, which may improve chemotherapy resistance to gemcitabine in PC. Down-regulation of Girdin might due to this fact improve gemcitabine chemosensitivity in PC. Our outcomes reveal that Girdin acted as a destructive regulator of gemcitabine chemosensitivity in PC.
Elevated autophagy exercise brought on by abnormally excessive Girdin expression could also be one of many principal elements for the discount in chemosensitivity, which can present new views on understanding chemosensitization in PC. Tumor molecular profile evaluation by Subsequent Technology Sequencing know-how is at present broadly utilized in medical apply and has enabled the detection of predictive biomarkers of response to focused remedy. In parallel with focused therapies, immunotherapies are additionally evolving, revolutionizing most cancers remedy, with Programmed Loss of life-ligand 1 (PD-L1), Microsatellite instability (MSI), and Tumor Mutational Burden (TMB) evaluation being the biomarkers employed mostly.
Human Lung cancer marker ELISA kit |
E01L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Lung cancer marker ELISA kit |
E01L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human lung cancer Marker ELISA Kit |
GA-E1674HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human lung cancer Marker ELISA Kit |
GA-E1674HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Lung cancer marker ELISA Kit |
EHL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Dog Lung cancer marker ELISA kit |
E08L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Lung cancer marker ELISA kit |
E08L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Lung cancer marker ELISA kit |
E08L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Lung cancer marker ELISA Kit |
ERL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Rat Lung cancer marker ELISA kit |
E02L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Lung cancer marker ELISA kit |
E02L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Lung cancer marker ELISA kit |
E02L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Lung cancer marker ELISA kit |
E07L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Lung cancer marker ELISA kit |
E07L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Lung cancer marker ELISA kit |
E07L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Lung cancer marker ELISA kit |
E06L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Lung cancer marker ELISA kit |
E06L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Lung cancer marker ELISA kit |
E06L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Lung cancer marker ELISA Kit |
EGTL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse Lung cancer marker ELISA Kit |
EML0303 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse Lung cancer marker ELISA kit |
E03L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Lung cancer marker ELISA kit |
E03L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Lung cancer marker ELISA kit |
E03L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Canine Lung cancer marker ELISA Kit |
ECL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit Lung cancer marker ELISA Kit |
ERTL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit Lung cancer marker ELISA kit |
E04L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Lung cancer marker ELISA kit |
E04L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Lung cancer marker ELISA kit |
E04L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Lung cancer marker ELISA kit |
E09L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Lung cancer marker ELISA kit |
E09L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Lung cancer marker ELISA kit |
E09L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Bovine Lung cancer marker ELISA Kit |
EBL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Porcine Lung cancer marker ELISA Kit |
EPL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Anserine Lung cancer marker ELISA Kit |
EAL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Guinea pig Lung cancer marker ELISA kit |
E05L0296-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Lung cancer marker ELISA kit |
E05L0296-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Lung cancer marker ELISA kit |
E05L0296-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea Pig Lung cancer marker ELISA Kit |
EGL0303 |
Abclonal |
96Tests |
EUR 625.2 |
Human tumor marker DR- 70 for lung cancer ELISA Kit |
ELA-E1259h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit |
201-12-1679 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit |
GA-E1695HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit |
GA-E1695HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human DR-70TM(Tumor Marker DR-70 For Lung Cancer) ELISA Kit |
EH2961 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ug/ml |
Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit |
QY-E03613 |
Qayee Biotechnology |
96T |
EUR 480 |
Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit |
YLA2714HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit |
YLA2714HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM) |
KTE62601-48T |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM) |
KTE62601-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM) |
KTE62601-96T |
Abbkine |
96T |
EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Lung cancer |
LC751 |
TissueArray |
each |
EUR 234 |
Description: Lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 25 cases/75 cores (core size 1.5mm),Recent Year Collection |
Lung Cancer Exosome |
P141-LG |
101Bio |
- |
Ask for price |
Lung cancer with matched cancer adjacent lung tissue array |
LC481 |
TissueArray |
each |
EUR 168 |
Description: Lung cancer with matched cancer adjacent lung tissue array, including pathology grade, TNM and clinical stage, 12 cases/48 cores |
Lung cancer with lung tissue array |
LC1503 |
TissueArray |
each |
EUR 258 |
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma fererence AJCC 8th edition), 75 cases/150 cores, replacing LUC1503 |
Lung cancer with lung tissue array |
LC483a |
TissueArray |
each |
EUR 168 |
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th version), 48 cases/48 cores, replacing LC483 |
Lung cancer with lung tissue array |
LC8010 |
TissueArray |
each |
EUR 270 |
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 80 cases/80 cores, replacing LC801 |
Lung cancer with lung tissue array |
T043b |
TissueArray |
each |
EUR 66 |
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T043a |
Colon cancer and lung cancer tissue array |
CLC601 |
TissueArray |
each |
EUR 306 |
Description: Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores |
Stomach cancer and lung cancer tissue array |
SLC601 |
TissueArray |
each |
EUR 306 |
Description: Stomach cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores |
Lung Cancer Exosome RNA |
P241-LG |
101Bio |
- |
Ask for price |
Lung cancer tissue array |
NSC151 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores |
Lung cancer tissue array |
NSC153 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores |
Lung cancer tissue array |
NSC154 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, with ALK results,, 150 cases/150 cores |
Lung cancer tissue array |
NSC155 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores |
Lung cancer tissue array |
NSC156 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, 150 cases/150 cores |
Lung cancer tissue array |
NSC157 |
TissueArray |
each |
EUR 420 |
Description: Lung cancer tissue array, 150 cases/150 cores |
Lung cancer tissue array |
LC1261 |
TissueArray |
each |
EUR 354 |
Description: Lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1 (Sp263) information, 63 cases/126 cores |
Lung cancer tissue array |
LC243 |
TissueArray |
each |
EUR 198 |
Description: Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores |
Lung cancer tissue array |
LC485 |
TissueArray |
each |
EUR 198 |
Description: Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores |
Lung cancer tissue array |
LUN703 |
TissueArray |
each |
EUR 198 |
Description: Lung cancer tissue array,including pathology grade and TNM,7 cases/70 cores (core size 1.5mm) |
Lung cancer tissue array |
LC726b |
TissueArray |
each |
EUR 222 |
Description: Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing LC726 |
Lung cancer tissue array |
LC721 |
TissueArray |
each |
EUR 270 |
Description: Lung cancer tissue array, including TNM and pathology grade, 24 cases/72 cores |
Lung cancer tissue array |
VLC11 |
TissueArray |
each |
EUR 66 |
Description: Lung cancer tissue array, with TNM and grade info, 11 cases/11 cores |
Lung cancer tissue array |
VLC12b |
TissueArray |
each |
EUR 66 |
Description: Lung cancer tissue array, including pathology grade, TNM and clinical stage, 12 cases/12 cores, replacing VLC12a |
Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC marker (CD70 |
LC2163 |
TissueArray |
each |
EUR 552 |
Description: Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC marker (CD70, MPO and PD-L1), including pathology grade, TNM and clinical stage, 108 cases/216 cores(1.0mm) |
Lung cancer with lung tissue test array |
T045f |
TissueArray |
each |
EUR 66 |
Description: Lung cancer with lung tissue test array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T045e |
Lung cancer and normal lung tissue array |
LC482 |
TissueArray |
each |
EUR 198 |
Description: Lung cancer and normal lung tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores |
Lung cancer and normal lung tissue array |
LC811a |
TissueArray |
each |
EUR 270 |
Description: Lung cancer and normal lung tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 core |
Human ovarian cancer marker-CA125 ELISA Kit |
201-12-1663 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human ovarian cancer marker-CA125 ELISA Kit |
GA-E1679HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human ovarian cancer marker-CA125 ELISA Kit |
GA-E1679HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Ovarian cancer marker-CA125 ELISA Kit |
EHO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Multiple lung cancer with lung tissue array |
LC813b |
TissueArray |
each |
EUR 270 |
Description: Multiple lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma and atypical carcinoid are referencing AJCC 8th version), 79 cases/80 cores, replacing LC813a |
Non-small cell lung cancer |
LC871 |
TissueArray |
each |
EUR 258 |
Description: Non-small cell lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 29 cases/87 cores (core size 1.5mm),Recent Year Collection |
Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit |
201-12-1726 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit |
GA-E1742HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit |
GA-E1742HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit |
QY-E03620 |
Qayee Biotechnology |
96T |
EUR 495.6 |
Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit |
YLA2738HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit |
YLA2738HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
Lung cancer test tissue array |
T046a |
TissueArray |
each |
EUR 48 |
Description: Lung cancer test tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T046 |
Human Cancer PrimaCell11: Lung Tumor Cells |
2-96034 |
CHI Scientific |
1 Kit |
Ask for price |
Human ovarian cancer marker-CA125(CA125)ELISA Kit |
YLA1446HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human ovarian cancer marker-CA125(CA125)ELISA Kit |
YLA1446HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
High-density lung cancer array |
LC6161 |
TissueArray |
each |
EUR 954 |
Description: High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores |
Human Kita-kyushu lung cancer antigen 1 (CT83) |
1-CSB-EP711093HU |
Cusabio |
-
EUR 524.40
-
EUR 285.60
-
EUR 1852.80
-
EUR 783.60
-
EUR 1234.80
-
EUR 355.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in E.coli |
Human Kita-kyushu lung cancer antigen 1 (CT83) |
1-CSB-YP711093HU |
Cusabio |
-
EUR 604.80
-
EUR 318.00
-
EUR 2198.40
-
EUR 915.60
-
EUR 1459.20
-
EUR 400.80
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in Yeast |
Human Kita-kyushu lung cancer antigen 1 (CT83) |
1-CSB-MP711093HU |
Cusabio |
-
EUR 351.60
-
EUR 1155.60
-
EUR 490.80
-
EUR 860.40
|
|
|
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in Mammalian cell |
Multiple lung cancer tissue array |
LC20813c |
TissueArray |
each |
EUR 546 |
Description: Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores, replacing LC120813b |
Multiple lung cancer tissue array |
LC20815a |
TissueArray |
each |
EUR 546 |
Description: Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma is referenced AJCC 8th version), 208 cases/208 cores, replacing LC20815 |
High-density lung cancer with lung tissue array |
LC2085d |
TissueArray |
each |
EUR 546 |
Description: High-density lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 186 cases/208 cores, replacing LC2085c |
Lung cancer and matched adjacent lung tissue array |
LC486 |
TissueArray |
each |
EUR 168 |
Description: Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases/48 cores |
Lung cancer progression tissue array |
LC1005b |
TissueArray |
each |
EUR 270 |
Description: Lung cancer progression tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing LC1005a |
Early stage of lung cancer with lung tissue array |
LC820 |
TissueArray |
each |
EUR 306 |
Description: Early stage of lung cancer with lung tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores |
Lung cancer with lung tissue array (2015 WHOclassification) |
LC243a |
TissueArray |
each |
EUR 198 |
Description: Lung cancer with lung tissue array (2015 WHOclassification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 2 serial sections, 24 cases/48 cores, replacing LC243 |
Lung cancer and normal tissue array |
LC722 |
TissueArray |
each |
EUR 306 |
Description: Lung cancer and normal tissue array, with TNM and grade data, 24 cases/72 cores |
Lung cancer with lung tissue array (2015 WHO classification) |
LC1203A |
TissueArray |
each |
EUR 306 |
Description: Lung cancer with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 120 cases/120 cores, replacing BC041115d |
Lung cancer tissue array with adjacent normal lung tissue |
LC813a |
TissueArray |
each |
EUR 270 |
Description: Lung cancer tissue array with adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 78 cases/80 cores, replaced by LC813b |
Lung cancer with matched adjacent and cancer adjacent tissue array |
BC04022a |
TissueArray |
each |
EUR 168 |
Description: Lung cancer with matched adjacent and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 3 cores/case, replacing BC04022 |
Lung cancer tissue array (1 of 5) |
LC20812a |
TissueArray |
each |
EUR 546 |
Description: Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases/208 cores replacing LC20812 |
Lung cancer tissue array (2 of 5) |
LC20813 |
TissueArray |
each |
EUR 546 |
Description: Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases/208 cores, replaced by LC20813b |
Lung cancer tissue array (4 of 5) |
LC20815 |
TissueArray |
each |
EUR 546 |
Description: Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases/208 cores, replaced by LC20815a |
Lung cancer tissue array (5 of 5) |
LC20816 |
TissueArray |
each |
EUR 546 |
Description: Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores |
Lung cancer tissue array (5 of 5) |
LC20816a |
TissueArray |
each |
EUR 546 |
Description: Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores (cores size 1.0mm),replacing LC20816 |
Lung cancer tissue array with matched adjacent lung tissue |
LC488 |
TissueArray |
each |
EUR 168 |
Description: Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases/48 cores |
Cancer of the lung, 102 cases (1.5mm) |
LUC1021 |
Pantomics |
1 |
EUR 300 |
Description: Lung cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data.) tissues |
Cancer of the lung, 228 cases (1.1mm) |
LUC2281 |
Pantomics |
1 |
EUR 552 |
Description: Lung cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data. |
Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E01O0338-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E01O0338-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E01O0338-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC markers (PD-L1 |
LC2162 |
TissueArray |
each |
EUR 546 |
Description: Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC markers (PD-L1, ALK, ROS1+, LKB1, CD38, CD70, HLA1, MPO, CD3 and CD8, containing stained intensity, location and cell type), including pathology grade, TNM and clinical stage, 108 cases/216 cores (core size 1.0mm) |
Tumor molecular profile evaluation utilizing NGS is a first-tier methodology for quite a lot of tumor sorts and gives necessary data for determination making within the remedy of most cancers sufferers. Importantly, simultaneous evaluation for focused remedy and immunotherapy biomarkers may result in higher tumor characterization and supply actionable data within the majority of sufferers.